Innovations and Current Evidence in Radiotherapy for Urological Cancers
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 30 November 2026 | Viewed by 1
Special Issue Editor
Special Issue Information
Dear Colleagues,
Radiation therapy plays an essential and continually expanding role in the management of urological cancers, including prostate, kidney, urothelial, testicular, and penile malignancies. Recent advances in imaging, treatment planning, and delivery have enabled highly conformal dose increases, improved organ preservation, and optimized toxicity profiles. Furthermore, the integration of stereotactic body radiotherapy, image-guided adaptive techniques, particle therapy, and brachytherapy has expanded the therapeutic window for both localized and metastatic disease. Accumulating evidence supports the utility of metastasis-directed therapy, salvage radiotherapy strategies after local failure, and palliative regimens tailored to disease biology and patient-specific risk. In parallel, emerging biomarkers, radiogenomic approaches, and immuno-radiotherapy combinations are redefining precision oncology for urological tumors.
This Special Issue will present current clinical and translational research that reflects recent developments in this field. We welcome original investigations, balanced reviews, and multidisciplinary studies examining emerging treatment approaches, technological improvements, potential predictive markers, and contemporary outcomes. By gathering contributions spanning the range of urological oncology, this Special Issue will provide an updated overview of evidence informing radiation therapy and support continued refinement of strategies that enhance disease control, functional preservation, and patient-centered care.
Dr. Tomoyuki Makino
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- radiotherapy
- urological cancer
- prostate cancer
- kidney cancer
- urothelial cancer
- testicular cancer
- penile cancer
- palliative
- metastases
- salvage
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
